Nasasinuspray Sine Conservans Junior (Xylometazoline Hydrochloride)

• Xylometazoline hydrochloride acts on the nasal vasculature to relieve congestion associated with upper‑respiratory conditions.
• Nasal congestion due to common cold: reduces swelling of the nasal mucosa, improving airflow and easing breathing.
• Acute rhinitis: alleviates nasal obstruction and pressure by constricting dilated vessels in the nasal lining.

• Xylometazoline hydrochloride selectively stimulates alpha‑adrenergic receptors on the smooth muscle of nasal blood vessels. This activation causes vasoconstriction, which decreases blood flow to the nasal mucosa, leading to reduced edema and opening of the nasal passages. The localized effect provides rapid relief of congestion without significant systemic absorption when used as directed.

Xylometazoline nasal spray may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Nasal irritation or burning sensation
• Dryness of the nasal mucosa
• Sneezing or mild itching
• Headache
• Altered taste or bitter after‑taste
• Mild epistaxis (nosebleed)

Serious or Rare Side Effects

• Rebound nasal congestion (rhinitis medicamentosa) after prolonged use
• Nasal septum perforation with excessive or improper application
• Significant hypertension or tachycardia
• Allergic reactions such as rash, swelling, or anaphylaxis
• Ocular effects including blurred vision or increased intra‑ocular pressure
• Severe cardiovascular events in susceptible individuals

Before using Nasasinuspray Sine Conservans Junior, consider the following safety measures.

• Age limitation: not recommended for children under 2 years of age.
• Duration of use: limit to 3‑5 consecutive days to avoid rebound congestion.
• Pregnancy and lactation: safety not established; consult a healthcare professional.
• Cardiovascular disease: use with caution due to possible systemic vasoconstriction.
• Nasal trauma or recent surgery: avoid application to the affected area.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Xylometazoline may interact with other medications that affect vascular tone or sympathetic activity.

Major Interactions (Avoid)

• Concurrent use of other nasal decongestants: risk of excessive vasoconstriction and hypertension.
• Systemic sympathomimetics (e.g., pseudoephedrine): may amplify cardiovascular effects.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: possible attenuation of tachycardia but require monitoring.
• Antihypertensive agents: may reduce their efficacy.
• Monoamine oxidase inhibitors (MAOIs): potential for additive pressor response.
• Certain antidepressants (e.g., tricyclics): monitor for increased blood pressure.
• Herbal stimulants (e.g., ephedra): may enhance sympathomimetic activity.